SCHEMBL7863182

SCHEMBL7863182

O=C(c1cccc(Cl)c1)N1CC(CN2CCC(COCc3ccc(F)cc3)CC2)C(c2ccsc2)C1

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 6/20 0.54
MCHR1 Q99705 1/20 0.41
HSD11B1 P28845 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7863014 0.91 CCR5 (0.51) CCR5
SCHEMBL7868521 0.91 CCR5 (0.52) CCR5
SCHEMBL7875039 0.90 CCR5 (0.41) CCR5HSD11B1
SCHEMBL7868290 0.89 CCR5 (0.42) CCR5
SCHEMBL7868315 0.87 CCR5 (0.53) CCR5
SCHEMBL7871275 0.86 CCR5 (0.43) CCR5
SCHEMBL7874856 0.86 CCR5 (0.70) CCR5HSD11B1
SCHEMBL7871981 0.84 CCR5 (0.48) CCR5
SCHEMBL7874880 0.84 CCR5 (0.49) CCR5
SCHEMBL7869840 0.84 CCR5 (0.49) CCR5HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US claimed
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed